Poelarends Gerrit J, Serrano Hector, Johnson William H, Whitman Christian P
Division of Medicinal Chemistry, College of Pharmacy, The University of Texas, Austin, Texas 78712-1071, USA.
Biochemistry. 2005 Jul 5;44(26):9375-81. doi: 10.1021/bi050296r.
Malonate semialdehyde decarboxylase (MSAD) from Pseudomonas pavonaceae 170 catalyzes the metal ion-independent decarboxylation of malonate semialdehyde and represents one of three known enzymatic activities in the tautomerase superfamily. The characterized members of this superfamily are structurally homologous proteins that share a beta-alpha-beta fold and a catalytic amino-terminal proline. Sequence analysis, chemical labeling studies, site-directed mutagenesis, and NMR studies of MSAD identified Pro-1 as a key active site residue in which the amino group has a pKa value of 9.2. The available evidence suggests a mechanism involving polarization of the C-3 carbonyl group of malonate semialdehyde by the cationic Pro-1. A second critical active site residue, Arg-75, could assist in the reaction by placing the substrate's carboxylate group in a favorable conformation for decarboxylation. In addition to the decarboxylase activity, MSAD has a hydratase activity as demonstrated by the MSAD-catalyzed conversion of 2-oxo-3-pentynoate to acetopyruvate. In view of this activity, MSAD was incubated with 3-bromo- and 3-chloropropiolate, and the subsequent reactions were characterized. Both compounds result in the irreversible inactivation of MSAD, making them the first identified inhibitors of MSAD. Inactivation by 3-chloropropiolate occurs in a time- and concentration-dependent manner and is due to the covalent modification of Pro-1. The proposed mechanism for inactivation involves the initial hydration of the 3-halopropiolate followed by a rearrangement to an alkylating agent, either an acyl halide or a ketene. The results provide additional evidence for the hydratase activity of MSAD and further support for the hypothesis that MSAD and trans-3-chloroacrylic acid dehalogenase, the preceding enzyme in the trans-1,3-dichloropropene catabolic pathway, diverged from a common ancestor but conserved the necessary catalytic machinery for the conjugate addition of water.
来自孔雀石假单胞菌170的丙二酸半醛脱羧酶(MSAD)催化丙二酸半醛的非金属离子依赖性脱羧反应,是互变异构酶超家族中已知的三种酶活性之一。该超家族中已被表征的成员是结构同源的蛋白质,它们具有β-α-β折叠和催化性氨基末端脯氨酸。对MSAD进行的序列分析、化学标记研究、定点诱变和核磁共振研究确定Pro-1是关键的活性位点残基,其中氨基的pKa值为9.2。现有证据表明存在一种机制,即阳离子Pro-1使丙二酸半醛的C-3羰基极化。第二个关键的活性位点残基Arg-75可通过将底物的羧基置于有利于脱羧的构象中来辅助反应。除脱羧酶活性外,MSAD还具有水合酶活性,这已通过MSAD催化2-氧代-3-戊炔酸转化为乙酰丙酮酸得到证明。鉴于这种活性,将MSAD与3-溴丙炔酸酯和3-氯丙炔酸酯一起孵育,并对后续反应进行表征。这两种化合物都会导致MSAD不可逆失活,使其成为首批被鉴定出的MSAD抑制剂。3-氯丙炔酸酯导致的失活呈时间和浓度依赖性,是由于Pro-1的共价修饰。提出的失活机制涉及3-卤代丙炔酸酯的初始水合作用,随后重排为烷基化剂,即酰卤或乙烯酮。这些结果为MSAD的水合酶活性提供了更多证据,并进一步支持了以下假设:MSAD和反式-1,3-二氯丙烯分解代谢途径中的前一种酶反式-3-氯丙烯酸脱卤酶,虽从共同祖先分化而来,但保留了水共轭加成所需的催化机制。